The effect of Curcumin on Polycystic Ovary Syndrome.
Phase 3
Recruiting
- Conditions
- Polycystic Ovary Syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT20180503039511N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
PCOS diagnosis by a Specialist (Base on Rotterdam benchmark)
Women aged 18 to 40 Years Old (It is preferable not to be at the Age of Development or Menopause).
Body mass index larger equal to 25, smaller and equal to 35.
stability in the type and dose of medication in the last 6 months.
Lack of acute heart disease, Increased Prolactin levels, Liver, Kidney, Digestive, Thyroid and Diabetes, Androgens secreting Tumors.
Use of antioxidant supplements and drugs that affect inflammatory and oxidative stress factors.
Drug in the last 6 months
Exclusion Criteria
Unwilling to participate in the study
Pregnancy
Misdiagnosis of demographic or anthropometric information
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Malondialdehyde. Timepoint: The beginning and the end of the study. Method of measurement: Biochemistry.;Total Antioxidant Capacity. Timepoint: The beginning and the end of the study. Method of measurement: Biochemistry.
- Secondary Outcome Measures
Name Time Method Mean changes in the level of the C reactive protein. Timepoint: The beginning and the end of the study. Method of measurement: Biochemistry.;Depression anxiety stress score. Timepoint: The beginning and the end of the study. Method of measurement: Stress Anxiety Depression Questionnaire 7 question.